NeoGenesis Pharmaceuticals
NeoGenesis is a San Diego-based professional skincare and haircare company that sells regenerative products powered by its proprietary S²RM® stem cell secretome technology, serving consumers, dermatologists, oncologists, and estheticians across the US, Canada, UK, and Australia.
- Company typePrivate
- Founded1997
- HeadquartersCambridge, United States
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What NeoGenesis Pharmaceuticals does
NeoGenesis is a San Diego-based professional-grade skincare and haircare company that develops and sells regenerative products based on its proprietary S²RM® (Secretome-derived Natural Molecules) technology platform. The technology harnesses stem cell released molecules including exosomes, ectosomes, growth factors, peptides, cytokines, and soluble fractions derived from fibroblast, adipose mesenchymal, and dermal papillae stem cells, with over 30 years of underlying research originating from NIH-funded work at UC San Diego and Berkeley. The company was co-founded by Greg Maguire, a neuroscientist and regenerative medicine pioneer, and Steven T. McGee, a business leader. Its product portfolio spans serums, moisturizers, cleansers, mists, masks, exfoliants, and bundled kits for general skin health, anti-aging, hyperpigmentation, acne, rosacea, eczema, and wound care, alongside hair/lash/brow regenerative products, with a specialized oncology-friendly line addressing radiation dermatitis, chemotherapy side effects, and pre/post-cancer surgery recovery.
NeoGenesis operates a hybrid go-to-market combining direct-to-consumer e-commerce on its own website with a wholesale professional channel serving dermatologists, oncologists, estheticians, and spa professionals who integrate its products into clinical and service settings. Product pricing ranges from $20 to $342.50 depending on product and size, with free US shipping on orders over $350. The company distributes across the United States, Canada, the United Kingdom, and Australia through regional storefronts. It is a privately held company with only one disclosed institutional funding event, a $23 million round led by OrbiMed in 2001, and no identified parent company, subsidiaries, or subsequent recapitalizations. Headcount is reported at 11-50 employees and the company is actively operating and selling through its e-commerce platform.
NeoGenesis Pharmaceuticals firmographics
Firmographics- Name
- NeoGenesis Pharmaceuticals
- Legal name
- NeoGenesis
- Website
- https://neogenesis.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- NeoGenesis is a San Diego-based professional skincare and haircare company that sells regenerative products powered by its proprietary S²RM® stem cell secretome technology, serving consumers, dermatologists, oncologists, and estheticians across the US, Canada, UK, and Australia.
- Ownership category
- akta.pro rank
NeoGenesis Pharmaceuticals industry classification
Industry- Product category
- Regenerative Skincare Products
- NAICS
- Cosmetics, Beauty Supplies, and Perfume Retailers (456120), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB)
Keywords
Where NeoGenesis Pharmaceuticals is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
NeoGenesis Pharmaceuticals business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Operations, Marketing or Sales, Personnel
Revenue model
- Direct-to-Consumer E-commerce: Products sold directly to consumers through the company's e-commerce website, with prices ranging from $20 to $342.50 depending on the product and size. They offer free U.S. shipping over $350 USD and Canada shipping over $1,000 CAD.
- Wholesale/Professional Partnership: Products sold wholesale to medical professionals and estheticians who integrate NeoGenesis into their clinical practices and spas.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Recovery Serum - Stem cell released molecules for regenerative support |
| Unit Pricing | Pay-as-you-go | MB-2 Probiotic Balm - Barrier support and hydration |
| Unit Pricing | Pay-as-you-go | Barrier Renewal Cream - Skin barrier strengthening |
| Unit Pricing | Pay-as-you-go | Moisturizing Mist - Hydrating and toning mist |
| Unit Pricing | Pay-as-you-go | Hair Thickening Serum - Hair regrowth support |
| Unit Pricing | Pay-as-you-go | NeoLash - Eyelash enhancement |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
NeoGenesis Pharmaceuticals product offering
Product offeringCore offering
NeoGenesis develops and sells professional-grade regenerative skincare and haircare products powered by its proprietary S²RM® (Secretome-derived Small Regulatory Molecules) technology, which harnesses stem cell released molecules including exosomes, growth factors, peptides, and cytokines. Products are sold directly to consumers through an e-commerce storefront and wholesale to medical professionals and estheticians, with specialized oncology support kits for cancer patients.
Product overview
NeoGenesis is a professional-grade skincare and haircare company powered by proprietary S²RM® (Secretome-derived Small Regulatory Molecules) secretome science technology. The product portfolio centers on regenerative serums and moisturizers derived from stem cell-released molecules including exosomes, ectosomes, growth factors, peptides, cytokines, and soluble fractions. The core offerings include Recovery Serum, Skin Serum, Moisturizing Mist, and Barrier Renewal Cream for skincare, alongside Hair Thickening Serum, NeoLash, and NeoBrow for haircare. Specialized oncology support products address radiation dermatitis, chemotherapy side effects, and pre/post-cancer surgery recovery. Products are sold individually and as bundled kits, with professional-grade formulations available through wholesale channels for medical professionals and estheticians.
Differentiator
Problem solved
Functional benefit
Products and services
- Recovery Serum
Quantifiable outcome
- Patients reported minimal or no radiation burns during treatment with consistent use of NeoGenesis products
- +2 more outcomes
Companies that use NeoGenesis Pharmaceuticals
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
NeoGenesis Pharmaceuticals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
NeoGenesis Pharmaceuticals partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights5 records
NeoGenesis Pharmaceuticals competitors and assessment
Company assessmentMarket position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks4 records
Key highlights6 records
Customer concentration
NeoGenesis Pharmaceuticals social profiles
Digital presenceNeoGenesis Pharmaceuticals financial estimates
Financial estimateRevenue estimate
Valuation estimate
NeoGenesis Pharmaceuticals leadership team
Management profileNumber of profiles
Profiles2 records
NeoGenesis Pharmaceuticals funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NeoGenesis Pharmaceuticals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NeoGenesis Pharmaceuticals
What does NeoGenesis Pharmaceuticals do?
NeoGenesis develops and sells professional-grade regenerative skincare and haircare products powered by its proprietary S²RM® (Secretome-derived Small Regulatory Molecules) technology, which harnesses stem cell released molecules including exosomes, growth factors, peptides, and cytokines. Products are sold directly to consumers through an e-commerce storefront and wholesale to medical professionals and estheticians, with specialized oncology support kits for cancer patients.
Is NeoGenesis Pharmaceuticals a public or private company?
NeoGenesis Pharmaceuticals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was NeoGenesis Pharmaceuticals founded?
NeoGenesis Pharmaceuticals was founded in 1997. It employs 11 to 50 people.
Where is NeoGenesis Pharmaceuticals based?
NeoGenesis Pharmaceuticals is headquartered in Cambridge, United States, in the North America region.
How does NeoGenesis Pharmaceuticals make money?
Two revenue lines are on record. Direct-to-Consumer E-commerce is the primary driver. The others are wholesale/Professional Partnership.
Does NeoGenesis Pharmaceuticals have an API?
No public API is recorded for NeoGenesis Pharmaceuticals.
What industry is NeoGenesis Pharmaceuticals in?
NeoGenesis Pharmaceuticals's product category is Regenerative Skincare Products. Its primary akta.pro industry code is CRABAAAB, Treatment Skincare (Serums, Actives, Acne & Anti-aging). Its NAICS code is 456120 and its SIC code is 2844.